This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A second look at the use and clinical efficacy of Hyaluronic acid for patients with osteoarthritis and the current treatment landscape

Ticker(s): SNY, PCRX

Who's the expert?

Institution: Duke Lifepoint Physicians

  • Board-certified Orthopedic Surgeon and sports medicine specialist
  • treats approximately 20 patients with knee osteoarthritis per week and performs HA injections 30-40 times per month
  • specializes in sports medicine, shoulder and knee arthroscopy, rotator cuff repair, shoulder instability surgery, ACL reconstruction, fracture surgery, shoulder and knee replacement surgery and general orthopedic surgery

Interview Goal
Despite FDA warning against the use of HA injections, the number of injections performed has increased so this discussion will be focused on a doctors view on the matter and their use of HA injections over the past 10 years.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.